Hemosol sells tax losses to MDS for $16 million

Guest Contributor
March 3, 2004

Hemosol Inc has once again sidestepped insolvency through a complex agreement with MDS Inc that will see the Toronto-based firm receive $16 million for the sale of accumulated tax losses and other tax assets. The agreement — subject to approval by the Ontario courts and shareholder consideration — will see the creation of Hemosol Corp and the renaming of Hemosol Inc to Opco. MDS, which currently holds 12% of Hemosol Inc shares will own 99.5% of Opco shares. Opco, in turn, will own 7% of Hemosol Corp with the latter being the successor to


Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.